Degenerative conditions OA Flashcards

1
Q

what is sarcopenia

A

the loss of skeletal muscle mass and strength as a result of ageing.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

how much muscle mass do you loose between the ages of 30-80

A

Normal individuals exhibit an approx. 30% decrease in total muscle mass (sarcopenia) between the ages of 30 to 80 years.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what is the cause of sarcopenia

A

low sex hormones

low IGF-1 levels

decrease in activity

osteoarthritis and neuronal degeneration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

describe how much muscle mass you loose per decade after the age of 30

A

3% to 5% of muscle mass lost per decade after age 30

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what does loss of muscle mass lead to

A

Leads to camptocormia,

frailty and falls

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what are the three reasons for loss of height with age

A

1, disc degeneration
2, sarcopenia and camptocormia
3, osteoporosis and vertebral collapse

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

how do you prevent and treat sarcopenia

A
  • Exercise
  • vitamin D repletion
  • HRT if menopause is premature
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is spondylosis

A

Degenerative condition of discal articulation of the spine.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

describe what an osteoarthritis radiography looks like

A
  • evidence of cartilage loss - joint space narrowing

- evidence of bone response (presence of osteophytes and sclerosis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what are risk factors for osteoarthritis

A

Obesity especially OA knee

Abnormal mechanical loading eg menisectomy, instability and dysplasia

Inherited type II collagen in premature polyarticular OA

Inheritance in nodal OA

Occupation eg farmers & OA hip

Non-gonococcal septic arthritis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what are herberdens nodes

A

Heberden’s nodes are bony swellings of the DIP joint or distal interphalangeal join

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are bouchards nodes

A

Bouchard’s nodes are hard, bony outgrowths or gelatinous cysts on the proximal interphalangeal joints (the middle joints of fingers or toes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Name nodal generalised OA

A

Heberden’s nodes

Bouchard’s nodes

CMC of thumb

Hallux valgus/rigidus

Knees & hips

Apophyseal joints- synovial joints at the back of the spine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is Hallux valgus

A

Hallux valgus is a deformity of the first metatarsophalangeal joint

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what is crystal associated OA

A
  • this is when there is calcium deposition within the cartilage
  • calcium pyrophosphate dehydrate occurs mainly in elderly women and affects the knee principally
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what is crystal associated OA associated with

A

hips and shoulders and knees of elderly women

- often has a poor outcome

17
Q

what can cause OA of premature onset

A

Previous menisectomy

Haemochromatosis

18
Q

What are the physical signs in OA

A

Crepitus

Bony enlargement

Deformity

Instability

Restricted movement

Effusion

Muscle weakness or wasting

19
Q

name an exercise that you can do for OA of the knee

A
  • Quadriceps building exercises for OA of the knee
  • rise it up
  • count from 1-10 and put it down
  • this reduces the risk of falling
20
Q

how many people does osteoporosis affect

A

affects an estimated 75 million people in Europe, the US, and Japan; this figure is projected to double over the next 50 years1

21
Q

how many people experience an osteoporotic fracture

A

1 in 2 women and 1 in 5 men over the age of 50 worldwide will experience an osteoporotic fracture

22
Q

what does an osteoporotic spine look like

A

it is kyphotic

23
Q

describe the fracture cascade

A
  • in patients who have already have a fracture there is an increased risk of 86% of sustaining another fracture
24
Q

what is the three types of osteoporosis

A

Type I (postmenopausal)

Type II (senile)

Idiopathic(at ages <50

25
Q

as you increase in age what fractures become higher

A
  • vertebrae and hip increase in prevalence

- colles increases but more or less stays stable

26
Q

how many women have vertebral fractures

A

Vertebral fractures affect 20 % of women.

Most vertebral fractures are asymptomatic.

27
Q

how many women are affected by hip fractures

A

Hip fractures affect 25 % of women living to the age 85.

28
Q

what are the clinical consequences of osteoporosis

A

Increased mortality- 20% in the first year after a hip fracture

Pain-early after fracture, prolonged pain due to secondary OA,costal margin impingement

Deformities-kyphosis,loss of height,abdominal protrusion

Loss of independence

29
Q

How can we prevent osteoporosis

A

☻Ensure an adequate calcium intake which meets the relevant dietary recommendations
in the country or region where they live

☻Avoid undernutrition and protein malnutrition

☻Maintain an adequate supply of vitamin D through sufficient exposure to the sun and through
diet

☻Participate in regular physical activity

☻Avoid smoking

☻Be educated about the risk of high alcohol consumption

30
Q

how can you optimise peak bone mass

A

Exercise- regular and weight-bearing

Dietary Calcium-especially during growth

31
Q

How do you reduce the rate of bone loss

A

Regular exercise

Maintain calcium intake

Moderate alcohol intake

Stop smoking

HRT in selective cases

32
Q

what other measures can you use to protect against osteoporosis

A

Prevention of falls

Hip protectors

Patient’s education

33
Q

Name the treatment of osteoporosis

A

Bisphosphonates- etidronate, alendronate, risedronate, ibandronate, pamidronate and zoledronate

Selective oestrogen receptor modulators –raloxifene

HRT in selective cases

Vitamin D & Calcium

Teriparatide in severe unresponsive cases (bone forming)

Denosumab